Last reviewed · How we verify
NCT04733911
Recovery Kinetics Following Eccentric Exercise
NA trial testing 75 eccentric contractions in Muscle Damage in 10 participants. Completed in 30 April 2022.
28 February 2022
Quick facts
| Lead sponsor | University of Thessaly |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 10 |
| Start date | 1 April 2021 |
| Primary completion | 28 February 2022 |
| Estimated completion | 30 April 2022 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- 75 eccentric contractions
- 150 eccentric contractions
- 300 eccentric contractions
Conditions studied
- Muscle Damage — all drugs for Muscle Damage →
Sponsor
University of Thessaly
Who can join
Adults 18 to 30, male only, with Muscle Damage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study will be to investigate the recovery kinetics of neuromuscular fatigue, muscle microtrauma indicators, performance and oxidative stress factors after three different exercise induced muscle damage (EIMD) protocols in adult Males. Also, this study will determine the comparison among three different eccentric protocols in neuromuscular fatigue, muscle microtrauma indicators, performance and oxidative stress factors. The eccentric protocols will be differentiated in training volume and specifically in the eccentric repetitions in isokinetic dynamometer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04733911
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Muscle Damage
Currently open trials in the same condition.
- NCT06837298 — The Effect of Vicia Faba Hydrolysate Supplementation on Muscle Strength Recovery · NA · recruiting
- NCT06432868 — Solarplast (R) Supplementation Effects Following High-intensity Resistance Exercise · NA · recruiting
- NCT06992271 — Comparing Two Eccentric Protocols on Muscle Damage · NA · recruiting
- NCT04900506 — Surgical Approach in Hemiarthroplasty. A Randomized Clinical Trial Comparing Posterior and Anterior Approach · NA · active not recruiting
- NCT04549610 — HMB and Exercise-induced Muscle Damage · Phase 2, PHASE3 · recruiting
Other University of Thessaly trials
Trials by the same sponsor.
- NCT07376187 — Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases · NA · not yet recruiting
- NCT07496151 — The Effectiveness of Neurodevelopmental Treatment (Bobath) and Functional Physiotherapy in Children With Cerebral Palsy. · NA · not yet recruiting
- NCT07420309 — Colonoscopy TRaining With or Without Artificial INtelligence Among Endoscopy Residents · NA · recruiting
- NCT07341711 — Long-term Adaptations of Skeletal Muscle After Hybrid Training. · NA · not yet recruiting
- NCT07380009 — Acceptability and Adherence to Different Dosing Regimens of the Multistrain Probiotic Vivomixx® 460 Neo 9 in Adults Rece · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04733911 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Thessaly
- Last refreshed: 10 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04733911.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing